Caris Life Sciences Inc
CAI28.600USD
+1.080+3.92%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
7.95BCap. mercado
PérdidaP/E TTM
Más Datos de Caris Life Sciences Inc Compañía
Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.
Información de la empresa
Símbolo de cotizaciónCAI
Nombre de la empresaCaris Life Sciences Inc
Fecha de salida a bolsaJun 18, 2025
Fundada en2020
Director ejecutivoMr. David Dean Halbert
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalJun 18
Dirección750 West John Carpenter Freeway
CiudadIRVING
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal75039
Teléfono18667718946
Sitio Webhttps://www.carislifesciences.com/
Símbolo de cotizaciónCAI
Fecha de salida a bolsaJun 18, 2025
Fundada en2020
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
526.22K
--
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
--
Vijay Mohan
Vijay Mohan
Independent Director
Independent Director
--
--
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
J. Russel Denton
J. Russel Denton
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
--
--
Dr. Jeffrey L. (Jeff) Vacirca, M.D.
Dr. Jeffrey L. (Jeff) Vacirca, M.D.
Independent Director
Independent Director
--
--
Dr. David Spetzler, Ph.D.
Dr. David Spetzler, Ph.D.
President
President
--
--
Nathan Burns
Nathan Burns
Independent Director
Independent Director
--
--
Ms. Laura I. Johansen
Ms. Laura I. Johansen
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
526.22K
--
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
--
Vijay Mohan
Vijay Mohan
Independent Director
Independent Director
--
--
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
J. Russel Denton
J. Russel Denton
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
--
--
Desglose de ingresos
Sin datos
Sin datos
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: lun., 28 de jul
Actualizado: lun., 28 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Halbert (David D)
44.22%
Sixth Street Partners, LLC
8.34%
J.H. Whitney Capital Partners, LLC
7.29%
Castleman Peter M
3.73%
Millennium Management LLC
1.29%
Other
35.13%
Accionistas
Accionistas
Proporción
Halbert (David D)
44.22%
Sixth Street Partners, LLC
8.34%
J.H. Whitney Capital Partners, LLC
7.29%
Castleman Peter M
3.73%
Millennium Management LLC
1.29%
Other
35.13%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
49.04%
Investment Advisor
10.07%
Private Equity
7.29%
Hedge Fund
1.29%
Investment Advisor/Hedge Fund
0.51%
Other
31.81%
Participación institucional
Actualizado: mié., 2 de jul
Actualizado: mié., 2 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
18
185.77M
66.84%
+183.22M
2025Q2
18
185.77M
66.84%
+183.22M
2025Q1
3
2.55M
0.92%
+2.55M
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Halbert (David D)
122.91M
44.22%
+120.52M
+5055.47%
Jun 18, 2025
Sixth Street Partners, LLC
25.64M
9.22%
+25.64M
--
Jun 18, 2025
J.H. Whitney Capital Partners, LLC
20.26M
7.29%
+20.26M
--
Jun 18, 2025
Castleman Peter M
10.37M
3.73%
+10.34M
+32049.87%
Jun 18, 2025
Millennium Management LLC
3.58M
1.29%
+3.58M
--
Jun 17, 2025
Halbert (Jon S.)
1.35M
0.49%
+1.22M
+920.73%
Jun 18, 2025
Poste (George H)
526.22K
0.19%
+526.22K
--
Jun 18, 2025
Ver más
ETFs relacionados
Nombre
Proporción
Sin datos
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
